Nuclera

📍 Cambridge, United Kingdom🗓 Founded 2013👥 131 employees💰 Last funded Oct 2024
Biotechnology Research🌐 nuclera.com?utm_source=linkedin&utm_medium=social&utm_campaign=company%2Bpage%2Bweb%2Blink
Website LinkedIn
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system. Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.
3
Total investors
0
Early stage
1
Mid stage
1
Late stage
2013
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
3
Investor activity2018–2024 · investors recorded per year
201812022120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Nuclera?
Nuclera has 3 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Nuclera last raise funding?
The most recent investment in Nuclera recorded on gritt.io was in October 2024.
When was Nuclera founded?
Nuclera was founded in 2013.
What industry is Nuclera in?
Nuclera operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nuclera based?
Nuclera is headquartered in Cambridge, United Kingdom.